This research thesis explores the computer-aided design, chemical synthesis and biochemical testing of novel molecules that target a CNS protein to aid in the development of safe drugs for neurological disorders, including Alzheimer's disease and schizophrenia.
Campus location
AustraliaPrincipal supervisor
Ben CapuanoAdditional supervisor 1
Karen J. GregoryAdditional supervisor 2
Peter J. ScammellsYear of Award
2025Department, School or Centre
Medicinal ChemistryCourse
Doctor of PhilosophyDegree Type
DOCTORATEFaculty
Faculty of Pharmacy and Pharmaceutical SciencesRights Statement
The author retains copyright of this thesis. It must only be used for personal non-commercial research, education and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission. For further terms use the In Copyright link under the License field.
